Literature DB >> 35052763

Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Piero Portincasa1, Leonilde Bonfrate1, Mohamad Khalil1,2, Maria De Angelis2, Francesco Maria Calabrese2, Mauro D'Amato3,4, David Q-H Wang5, Agostino Di Ciaula1.   

Abstract

The largest surface of the human body exposed to the external environment is the gut. At this level, the intestinal barrier includes luminal microbes, the mucin layer, gastrointestinal motility and secretion, enterocytes, immune cells, gut vascular barrier, and liver barrier. A healthy intestinal barrier is characterized by the selective permeability of nutrients, metabolites, water, and bacterial products, and processes are governed by cellular, neural, immune, and hormonal factors. Disrupted gut permeability (leaky gut syndrome) can represent a predisposing or aggravating condition in obesity and the metabolically associated liver steatosis (nonalcoholic fatty liver disease, NAFLD). In what follows, we describe the morphological-functional features of the intestinal barrier, the role of major modifiers of the intestinal barrier, and discuss the recent evidence pointing to the key role of intestinal permeability in obesity/NAFLD.

Entities:  

Keywords:  intestine; metabolic syndrome; metabolome; microbiota

Year:  2021        PMID: 35052763      PMCID: PMC8773010          DOI: 10.3390/biomedicines10010083

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  675 in total

1.  Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?

Authors:  A Cornet; T C Savidge; J Cabarrocas; W L Deng; J F Colombel; H Lassmann; P Desreumaux; R S Liblau
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

Review 2.  Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.

Authors:  John Y L Chiang; Preeti Pathak; Hailiang Liu; Ajay Donepudi; Jessica Ferrell; Shannon Boehme
Journal:  Dig Dis       Date:  2017-03-01       Impact factor: 2.404

3.  Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.

Authors:  John Willy Haukeland; Jan Kristian Damås; Zbigniew Konopski; Else Marit Løberg; Terese Haaland; Ingeborg Goverud; Peter A Torjesen; Kåre Birkeland; Kristian Bjøro; Pål Aukrust
Journal:  J Hepatol       Date:  2006-03-20       Impact factor: 25.083

4.  Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.

Authors:  Phillipp Hartmann; Peng Chen; Hui J Wang; Lirui Wang; Declan F McCole; Katharina Brandl; Peter Stärkel; Clara Belzer; Claus Hellerbrand; Hidekazu Tsukamoto; Samuel B Ho; Bernd Schnabl
Journal:  Hepatology       Date:  2013-05-27       Impact factor: 17.425

5.  Tributyrin supplementation protects mice from acute ethanol-induced gut injury.

Authors:  Gail A Cresci; Katelyn Bush; Laura E Nagy
Journal:  Alcohol Clin Exp Res       Date:  2014-05-30       Impact factor: 3.455

6.  Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.

Authors:  Isabel Gómez-Hurtado; Alba Moratalla; Ángela Moya-Pérez; Gloria Peiró; Pedro Zapater; José M González-Navajas; Paula Giménez; José Such; Yolanda Sanz; Rubén Francés
Journal:  J Hepatol       Date:  2014-06-02       Impact factor: 25.083

7.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 8.  What to do about the leaky gut.

Authors:  Michael Camilleri; Adrian Vella
Journal:  Gut       Date:  2021-09-11       Impact factor: 31.793

9.  Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease.

Authors:  Lucie Etienne-Mesmin; Matam Vijay-Kumar; Andrew T Gewirtz; Benoit Chassaing
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-05-05

10.  (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle.

Authors:  Emilio Molina-Molina; Harshitha Shanmugam; Agostino Di Ciaula; Ignazio Grattagliano; Domenica Maria Di Palo; Vincenzo O Palmieri; Piero Portincasa
Journal:  JHEP Rep       Date:  2020-11-04
View more
  13 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

2.  Alisol B 23-Acetate Ameliorates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction by Inhibiting TLR4-NOX1/ROS Signaling Pathway in Caco-2 Cells.

Authors:  Fan Xia; Yuxin Li; Lijun Deng; Ruxia Ren; Bingchen Ge; Ziqiong Liao; Shijian Xiang; Benjie Zhou
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

3.  Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.

Authors:  Aoxiang Zhuge; Shengjie Li; Pengcheng Lou; Wenrui Wu; Kaiceng Wang; Yin Yuan; Jiafeng Xia; Bo Li; Lanjuan Li
Journal:  Microbiol Spectr       Date:  2022-06-01

4.  Clinical and Metabolomic Effects of Lactiplantibacillus plantarum and Pediococcus acidilactici in Fructose Intolerant Patients.

Authors:  Piero Portincasa; Giuseppe Celano; Nadia Serale; Paola Vitellio; Francesco Maria Calabrese; Alexandra Chira; Liliana David; Dan L Dumitrascu; Maria De Angelis
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

Review 5.  Time to Consider the "Exposome Hypothesis" in the Development of the Obesity Pandemic.

Authors:  Victoria Catalán; Iciar Avilés-Olmos; Amaia Rodríguez; Sara Becerril; José Antonio Fernández-Formoso; Dimitrios Kiortsis; Piero Portincasa; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

6.  Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies.

Authors:  Francesca Baldini; Mohamad Khalil; Alice Bartolozzi; Massimo Vassalli; Agostino Di Ciaula; Piero Portincasa; Laura Vergani
Journal:  Biomolecules       Date:  2022-05-23

Review 7.  The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment.

Authors:  Binbin Zhang; Jianan Zhao; Minjie Jiang; Dandan Peng; Xiaobing Dou; Yu Song; Junping Shi
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

8.  Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis.

Authors:  Séverine Olivier; Hanna Diounou; Camille Pochard; Lisa Frechin; Emilie Durieu; Marc Foretz; Michel Neunlist; Malvyne Rolli-Derkinderen; Benoit Viollet
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

Review 9.  Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mirco Vacca; Maria De Angelis; Ilaria Farella; Elisa Lanza; Mohamad Khalil; David Q-H Wang; Markus Sperandio; Agostino Di Ciaula
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

10.  RNAseq of Osteoarthritic Synovial Tissues: Systematic Literary Review.

Authors:  Logan Moore; Zui Pan; Marco Brotto
Journal:  Front Aging       Date:  2022-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.